Jointly provided by Medical Education Resources, Inc and Impact Education, LLC.
|
This activity is supported by an independent educational grant from Dexcom, Inc.
|
Wednesday, March 30, 2022
6:00 AM - 6:30 AM - Registration and Breakfast
6:30 AM - 8:00 AM - Program
McCormick Place Lakeside Center
Room: E350
Chicago, IL
Please note: Registration for AMCP 2022 is not required to attend this symposium.
|
|
The on-demand CE archive of this symposium is now available at:
https://www.managedcarecgm.com/rtcgmoutcomes/
|
|
Learn About
|
- The latest data supporting the use of real-time CGM (rtCGM) and how it improves patient outcomes
- How diabetes technology increases patient engagement and self-management across diverse member populations
- The positive impact of electronic prior authorization for rtCGM under the pharmacy benefit
|
Expert Faculty Presenters
|
|
|
|
|
Samir Mistry, PharmD, MBA
Vice President of Pharmacy Strategy & Services
Capital Blue Cross
|
|
Monica Peek, MD, MPH
Professor of Medicine
Associate Director, Chicago Center for Diabetes Translational Research
The University of Chicago Medicine
|
|
Patient Advocate
|
|
|
|
Who Should Attend?
|
This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, registered nurses, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP 2022 Managed Care and Specialty Pharmacy Annual Meeting.
|
|
Statement of Need/Program Overview
|
The true impact of diabetes-related severe hypoglycemia (SH) events is often underestimated by payers, with only approximately 5% of self-reported events among pharmacologically treated patients being captured by health care utilization-based surveillance. Continuous glucose monitoring (CGM) represents a significant advancement in the precision management of type 2 diabetes (T2D), providing members from diverse demographics, including minority populations, with the ability to receive a virtually uninterrupted stream of information about the current physiology of their disease. However, many providers cite that prior authorizations may delay treatment and negatively impact clinical outcomes. A smart edit featuring an automated look back in claims data for a previous insulin prescription can be used as the criterion for approval with real-time adjudication, easing the administrative burden for payers and providers and streamlining access for members. This approach serves as a basic blueprint for payers to apply the latest evidence in advancing T2D management with optimal outcomes and cost reduction.
|
|
Educational Objectives
|
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Review the latest data supporting the use of rtCGM to improve patient outcomes and reduce resource utilization in T1 and T2D
- Assess the impact of social determinants of health (SDOH) on outcomes in diabetes among low-income and racial/ethnic minority populations
- Describe the role of diabetes technology in increasing patient engagement and self-management across diverse member populations of varying age, race/ethnicity, income, and insurance type
- Discuss the positive impact of electronic prior authorization for rtCGM under the pharmacy benefit in terms of provider administrative burden, access, and total cost of care
|
|
Agenda
|
Date and Time
Wednesday, March 30, 2022
6:00 AM - 6:30 AM - Registration and Breakfast
6:30 AM - 8:00 AM - Program
McCormick Place Lakeside Center
Room: E350
Chicago, IL
|
|
6:00 AM
|
Registration and Breakfast
|
|
6:30 AM
|
Welcome and Pre-Activity Assessment
Moderator
|
|
6:35 AM
|
The Latest Findings Demonstrating Improved Outcomes and Reduced Resource Utilization with rtCGM in T1 and T2D
Monica Peek, MD, MPH
|
|
7:05 AM
|
Real-Time Continuous Glucose Monitoring Case Scenarios and Follow-up Panel Discussions
- Enhancing Patient Engagement and Self-Management
- Addressing SDOH in Comprehensive Diabetes Programming
- The Role of Streamlined Coverage and Access in Timely and Effective Care
Monica Peek, MD, MPH; Samir Mistry, PharmD, MBA; Managed Care Faculty; Patient Advocate
|
|
7:45 AM
|
Audience Q&A Session
|
|
7:55 AM
|
Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
|
|
8:00 AM
|
Adjournment
|
|
 |
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Impact Education, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
|
